GIN1: A Drug Target / Disease Biomarker (G54826)

Target Name: GIN1

NCBI ID: G54826

GIN1

GIN1: A Drug Target / Disease Biomarker

GIN1, also known as G protein-coupled receptor GPCR, is a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are a common protein family that is expressed in most tissues and cells, and they are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling.

GIN1 is a GPCR that is expressed in the brain and is involved in several important brain functions, including motor coordination, learning, and memory. It is also involved in the regulation of pain perception and in the modulation of emotional responses.

Recent studies have suggested that GIN1 may be a potential drug target for a variety of psychiatric and neurological disorders, including depression, anxiety, and schizophrenia. This is because GIN1 is involved in the regulation of a wide range of neurotransmitters, including dopamine, serotonin, and norepinephrine, which are involved in mood, emotion, and other aspects of brain function.

In addition to its role in neurotransmission, GIN1 is also involved in the regulation of cellular signaling pathways that are involved in cancer progression. This is because GIN1 is a negative regulator of the TGF-β pathway, which is a well-known regulator of cell growth and differentiation that is involved in the development of cancer.

GIN1 has also been shown to play a role in modulating the immune response, which is important for maintaining the integrity of the body's immune system and preventing the development of diseases. This is because GIN1 is involved in the regulation of the chemokine receptor, which is a protein that is involved in the signaling of T cells and other immune cells.

In conclusion, GIN1 is a GPCR that is involved in a wide range of important physiological processes in the brain and body. Its potential as a drug target makes it an attractive target for the development of new treatments for psychiatric and neurological disorders. Further research is needed to fully understand the role of GIN1 in cellular signaling and its potential as a drug target.

Protein Name: Gypsy Retrotransposon Integrase 1

The "GIN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GIN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets